cdk4 glutathione MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation Inhibition of METTL14 overcomes CDK4/6
Inhibition of METTL14 overcomes CDK4 6 inhibitor resistance driven by METTL14 m6A E2F1 axis in ER positive breast cancer Journal of Nanobiotechnology Springer Nature Link Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research Targeting CDK4 6 for Anticancer Therapy CDK4 6 inhibitor mediated cell overgrowth triggers osmotic and replication stress to promote senescence: Molecular Cell Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




